JOE GORELICK: Open Payments
NPI 1811061369 · SAN JOSE, CA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$173,903 in 392 payments from 28 companies in 2025. Trend: 2023 $131,090 · 2024 $162,201 · 2025 $173,903
Speaker / faculty: $91,995Consulting: $35,719Travel & lodging: $24,805Food & beverage: $10,749Honoraria: $10,283Education: $352
| Company | Payments | Amount |
|---|---|---|
| LEO Pharma Inc. | 52 | $40,650 |
| UCB, Inc. | 68 | $33,237 |
| ABBVIE INC. | 41 | $17,365 |
| Janssen Biotech, Inc. | 41 | $17,206 |
| Lilly USA, LLC | 25 | $15,289 |
| Arcutis Biotherapeutics, Inc. | 21 | $11,612 |
| Galderma Laboratories, L.P. | 12 | $8,623 |
| Organon LLC | 12 | $6,353 |
| Incyte Corporation | 20 | $5,483 |
| Takeda Pharmaceuticals U.S.A., Inc. | 11 | $4,874 |
Products named: Bimzelx, ADBRY, TREMFYA, ZORYVE, ANZUPGO, SKYRIZI, RINVOQ, VTAMA.
Industry payments across CA — which companies pay providers there.
